Value of serum IgG4 level in differential diagnosis of IgG4-related pancreatic and hepatobiliary diseases and non-IgG4-related pancreatic and hepatobiliary diseases

Chang LI; Lei YAN; Li WANG; Chongxu HAN; Yunfeng YE; Defu JIN; Yuzhang JIANG

doi:10.3969/j.issn.1001-5256.2022.06.017

Volume 38 Issue 6

Jun. 2022

Turn off MathJax

Article Contents

Abstract

References

Article Navigation > Journal of Clinical Hepatology > 2022 > 38(6): 1307-1310

PDF( 1986 KB)

Value of serum IgG4 level in differential diagnosis of IgG4-related pancreatic and hepatobiliary diseases and non-IgG4-related pancreatic and hepatobiliary diseases

DOI: 10.3969/j.issn.1001-5256.2022.06.017

1.
Department of Clinical Laboratory, Huai'an No. 1 People's Hospital Affiliated to Nanjing Medical University, Huai'an, Jiangsu 223300, China
2.
Department of Clinical Laboratory, Xuzhou First People's Hospital, Xuzhou, Jiangsu 221000, China
3.
Department of Clinical Laboratory, Subei People's Hospital, Yangzhou, Jiangsu 225000, China
4.
Jiangsu College of Nursing, Huai'an, Jiangsu 223300, China

Research funding:

Huai'an City Innovation Service Capacity and Key Laboratory Construction Building Plan (HAP202004)

More Information

Corresponding author: JIANG Yuzhang, jyz8848@163.com (ORCID:0000-0002-8544-9485)
Received Date: 2021-10-01
Accepted Date: 2021-11-23
Published Date: 2022-06-20

Abstract

Abstract

Objective To investigate the value of serum IgG4 level in the differential diagnosis of IgG4-related pancreatic and hepatobiliary disease (IgG4-PHD) and non-IgG4-related disease (non-IgG4-RD). Methods Clinical data were collected from 491 patients who were hospitalized and 50 individuals who underwent physical examination in Huaian No. 1 People's Hospital Affiliated to Nanjing Medical University, Subei People's Hospital, and The First Affiliated Hospital of Xuzhou Medical University from August 2014 to April 2021. The 491 patients were divided into IgG4-PHD group with 20 patients, non-IgG4-RD autoimmune disease group with 431 patients (104 patients with systemic lupus erythematosus, 79 with rheumatoid arthritis, 174 with Sjogren's syndrome, 16 with ankylosing spondylitis, 11 with scleroderma, 4 with adult-onset Still's disease, 30 with myositis, 3 with psoriasis, and 10 with primary sclerosing cholangitis), and malignant pancreatic/hepatobiliary tumor group with 40 patients, and the 50 individuals undergoing physical examination were enrolled as healthy control group. Scattering immunoturbidimetric assay was used to measure serum IgG4 concentration. The two-sample Mann-Whitney U test was used for comparison of normally distributed continuous data between groups, and the Fisher's exact test was used for comparison of categorical data between groups. The receiver operating characteristic (ROC) curve was plotted to determine the optimal cut-off value of serum IgG4 in the diagnosis of IgG4-PHD. Results The IgG4-PHD group had a significantly higher serum IgG4 level than the non-IgG4-RD autoimmune disease groups, the malignant pancreatic/hepatobiliary tumor group, and the healthy control group (all P < 0.05), and the Sjogren's syndrome group had a significantly lower serum IgG4 level than the healthy control group (Z=2.958, P < 0.05). With serum IgG4 ≥1.35 g/L and IgG4 ≥2.01 g/L as the cut-off values, the IgG4-PHD group had a significantly higher positive rate than the non-IgG4-RD autoimmune disease group and the healthy control group (all P < 0.05). The ROC curve analysis showed that IgG4 had an area under the ROC curve of 0.980 in the differential diagnosis of IgG4-PHD and non-IgG4-RD autoimmune diseases, with a sensitivity of 100.00% and a specificity of 94.00% at the optimal cut-off value of 2.21 g/L. Conclusion Serum IgG4 level may also increase in non-IgG4-RD autoimmune diseases, while the cut-off value of 2.21 g/L can improve the differential diagnosis of IgG4-PHD and non-IgG4-RD autoimmune diseases, which requires further verification in clinical practice.
- Immunoglobulin G,
- Autoimmune Diseases,
- Diagnosis

FullText(HTML)

References(19)

References

[1]	LANZILLOTTA M, MANCUSO G, DELLA-TORRE E. Advances in the diagnosis and management of IgG4 related disease[J]. BMJ, 2020, 369: m1067. DOI: 10.1136/bmj.m1067.
[2]	YANG C, LI J, ZHANG YY, et al. Imaging findings of IgG4-related sclerosing mass pancreatitis and analysis of misdiagnosis[J]. Clin Misdiagn Misther, 2021, 305(1): 13-16. DOI: 10.3969/j.issn.1002-3429.2021.01.004. 杨超, 李进, 张优仪, 等. IgG4相关硬化性肿块型胰腺炎影像学表现及误诊分析[J]. 临床误诊误治, 2021, 305(1): 13-16. DOI: 10.3969/j.issn.1002-3429.2021.01.004.
[3]	DELLA-TORRE E, LANZILLOTTA M, DOGLIONI C. Immunology of IgG4-related disease[J]. Clin Exp Immunol, 2015, 181(2): 191-206. DOI: 10.1111/cei.12641.
[4]	WALLACE ZS, ZHANG Y, PERUGINO CA, et al. Clinical phenotypes of IgG4-related disease: an analysis of two international cross- sectional cohorts[J]. Ann Rheum Dis, 2019, 78(3): 406-412. DOI: 10.1136/annrheumdis-2018-214603.
[5]	LANZILLOTTA M, CAMPOCHIARO C, MANCUSO G, et al. Clinical phenotypes of IgG4-related disease reflect different prognostic outcomes[J]. Rheumatology (Oxford), 2020, 59(9): 2435-2442. DOI: 10.1093/rheumatology/keaa221.
[6]	MILOSLAVSKY EM, NADEN RP, BIJLSMA JW, et al. Development of a Glucocorticoid Toxicity Index (GTI) using multicriteria decision analysis[J]. Ann Rheum Dis, 2017, 76(3): 543-546. DOI: 10.1136/annrheumdis-2016-210002.
[7]	GHAZALE A, CHARI ST, ZHANG L, et al. Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy[J]. Gastroenterology, 2008, 134(3): 706-715. DOI: 10.1053/j.gastro.2007.12.009.
[8]	OTSUKI M, CHUNG JB, OKAZAKI K, et al. Asian diagnostic criteria for autoimmune pancreatitis: consensus of the Japan-Korea Symposium on Autoimmune Pancreatitis[J]. J Gastroenterol, 2008, 43(6): 403-408. DOI: 10.1007/s00535-008-2205-6.
[9]	WALLACE ZS, NADEN RP, CHARI S, et al. The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease[J]. Ann Rheum Dis, 2020, 79(1): 77-87. DOI: 10.1136/annrheumdis-2019-216561.
[10]	ZHANG DH, ZHAO J. Pathogenesis of immunoglobulin G4-related hepatobiliary and pancreatic diseases[J]. J Clin Hepatol, 2019, 35(6): 1401-1405. DOI: 10.3969/j.issn.1001-5256.2019.06.050. 张德华, 赵婕. IgG4相关性肝胆胰疾病的发病机制[J]. 临床肝胆病杂志, 2019, 35(6): 1401-1405. DOI: 10.3969/j.issn.1001-5256.2019.06.050.
[11]	OKAZAKI K, UCHIDA K, IKEURA T, et al. Current concept and diagnosis of IgG4-related disease in the hepato-bilio-pancreatic system[J]. J Gastroenterol, 2013, 48(3): 303-314. DOI: 10.1007/s00535-012-0744-3.
[12]	TANAKA A. IgG4-related sclerosing cholangitis and primary sclerosing cholangitis[J]. Gut Liver, 2019, 13(3): 300-307. DOI: 10.5009/gnl18085.
[13]	XU WL, LING YC, WANG ZK, et al. Diagnostic performance of serum IgG4 level for IgG4-related disease: A meta-analysis[J]. Sci Rep, 2016, 6(2): 32035. DOI: 10.1038/srep32035.
[14]	KHOSROSHAHI A, WALLACE ZS, CROWE JL, et al. International consensus guidance statement on the management and treatment of IgG4-related disease[J]. Arthritis Rheumatol, 2015, 67(7): 1688-1699. DOI: 10.1002/art.39132.
[15]	BERNASCONI L, MUNDWILER E, REGENASS S, et al. Variable and inaccurate serum IgG4 levels resulting from lack of standardization in IgG subclass assay calibration[J]. Clin Chem Lab Med, 2019, 57(11): 1777-1783. DOI: 10.1515/cclm-2019-0261.
[16]	TANG J, CAI S, YE C, et al. Biomarkers in IgG4-related disease: A systematic review[J]. Semin Arthritis Rheum, 2020, 50(2): 354-359. DOI: 10.1016/j.semarthrit.2019.06.018.
[17]	VALENZUELA NM, SCHAUB S. The biology of IgG subclasses and their clinical relevance to transplantation[J]. Transplantation, 2018, 102(1S Suppl 1): S7-S13. DOI: 10.1097/TP.0000000000001816.
[18]	USAMI Y, SUGANO M, UEHARA T, et al. Cut-off values of serum IgG4 among three reagents, including a novel IgG4 reagent: A multicenter study[J]. Sci Rep, 2021, 11(1): 7280. DOI: 10.1038/s41598-021-86024-5.
[19]	ZEGERS I, KELLER T, SCHREIBER W, et al. Characterization of the new serum protein reference material ERM-DA470k/IFCC: Value assignment by immunoassay[J]. Clin Chem, 2010, 56(12): 1880-1888. DOI: 10.1373/clinchem.2010.148809.

Relative Articles

[1]	Zhiran YANG, Linheng WANG, Yuan LI, Fusheng LIU, Yu WANG, Jianfang WANG, Runhua CHEN. Diagnostic value of transient elastography in the staging of hepatic fibrosis in patients with autoimmune liver disease: A Meta-analysis[J]. Journal of Clinical Hepatology, 2022, 38(1): 97-103. doi: 10.3969/j.issn.1001-5256.2022.01.015
[2]	Lili ZHANG, Aiwen GENG, Chuanwang QI, Jianchun XIAN. Association between immunoglobulin G4-related diseases and autoimmune hepatitis[J]. Journal of Clinical Hepatology, 2021, 37(12): 2972-2975. doi: 10.3969/j.issn.1001-5256.2021.12.050
[3]	Yu LeLe, Xiong Fang, Lu Jun. IgG4-related biliary and pancreatic diseases with significantly elevated CA19-9: A case report[J]. Journal of Clinical Hepatology, 2020, 36(5): 1129-1130. doi: 10.3969/j.issn.1001-5256.2020.05.039
[4]	Zhang DeHua, Zhao Jie. Pathogenesis of immunoglobulin G4-related hepatobiliary and pancreatic diseases[J]. Journal of Clinical Hepatology, 2019, 35(6): 1401-1405. doi: 10.3969/j.issn.1001-5256.2019.06.050
[5]	Han Lin, Yu Fan, Qin ShaoYou, Zhou ZhangYu. A case of IgG4-related autoimmune pancreatitis[J]. Journal of Clinical Hepatology, 2019, 35(2): 388-389. doi: 10.3969/j.issn.1001-5256.2019.02.032
[6]	Wang FuChuan, Zhang Min. An excerpt of diagnosis and management of paediatric autoimmune liver disease: ESPGHAN Hepatology Committee position statement (2017)[J]. Journal of Clinical Hepatology, 2018, 34(1): 46-52. doi: 10.3969/j.issn.1001-5256.2018.01.010
[7]	Qian JiaMing, Lai YaMin. Research history and perspectives of autoimmune pancreatitis[J]. Journal of Clinical Hepatology, 2018, 34(8): 1595-1598. doi: 10.3969/j.issn.1001-5256.2018.08.001
[8]	Mou Fei, Chen FangYing. Imaging diagnosis of autoimmune pancreatitis[J]. Journal of Clinical Hepatology, 2018, 34(8): 1604-1608. doi: 10.3969/j.issn.1001-5256.2018.08.003
[9]	Zhang PanPan, Zhang Wen. Application of immunosuppressant in IgG4-related autoimmune pancreatitis[J]. Journal of Clinical Hepatology, 2018, 34(8): 1614-1618. doi: 10.3969/j.issn.1001-5256.2018.08.005
[10]	Li YanNi, Zhou Lu, Zhang Jie, Deng BaoRu, Guo LiPing, Zhang Jun, Wang BangMao. Chronological changes in clinical features of autoimmune liver disease at initial diagnosis[J]. Journal of Clinical Hepatology, 2017, 33(1): 141-145. doi: 10.3969/j.issn.1001-5256.2017.01.031
[11]	Shi XiaoDong, Wei Qi, Yu Min, Liu XingXing, Jia ZhiFang, Wang YueQi, Jiang ZhenYu. Research advances in diagnosis and treatment of IgG4-associated autoimmune hepatitis[J]. Journal of Clinical Hepatology, 2016, 32(9): 1819-1821. doi: 10.3969/j.issn.1001-5256.2016.09.042
[12]	Yin Tao, Wu HeShui. Progress in diagnosis and treatment of autoimmune pancreatitis[J]. Journal of Clinical Hepatology, 2015, 31(5): 665-667. doi: 10.3969/j.issn.1001-5256.2015.05.006
[13]	Han Ying, Zhu JiangYi. Autoimmune sclerosing cholangitis: new concept and new evidence[J]. Journal of Clinical Hepatology, 2015, 31(2): 171-173. doi: 10.3969/j.issn.1001-5256.2015.02.006
[14]	Li WanYu, Qi Yue, Wu Na, Shi Yu, Cai YanJun. One case of autoimmune pancreatitis[J]. Journal of Clinical Hepatology, 2014, 30(8): 798-800. doi: 10.3969/j.issn.1001-5256.2014.08.025
[15]	Zhang Min, Han Tao, Li Ying, Xiao ShiXiang, Yan JunQing, Guo Zhen. Case of IgG4-related autoimmune pancreatitis with liver injury[J]. Journal of Clinical Hepatology, 2013, 29(7): 541-542. doi: 1001-5256 (2013) 07-0541-02
[16]	Zhou SuMin, Gao PuJun. Advancement in the treatment of two subtypes of autoimmune pancreatitis[J]. Journal of Clinical Hepatology, 2011, 27(11): 1219-1221.
[17]	Zhou SuMin, Gao PuJun, Gao RunPing. A case report of autoimmune pancreatitis[J]. Journal of Clinical Hepatology, 2011, 27(4): 424+43.
[18]	Bian ZhaoLian, You ZhengRui, Ma Xiong. The clinical analysis on endoscope technique applicated for patients suffering from extrahepatic cholestatic jaundice[J]. Journal of Clinical Hepatology, 2011, 27(6): 601-604.
[19]	Hu YuLin, Zhang Rong. Clinical features, diagnosis and treatment of autoimmune pancreatitis[J]. Journal of Clinical Hepatology, 2010, 26(5): 487-489.
[20]	Yang Li, Lu LunGen. 2010 American Association for the Study of Liver Diseases Guidelines for the Diagnosis and Treatment of Autoimmune Hepatitis [J]. Journal of Clinical Hepatology, 2010, 26(4): 344-347.

Supplements(0)

Cited By

Cited by

Periodical cited type(5)

1.	张航，骆丰，谢欢来，赵李楠，杨良俊，程东庆. 血清IgG4水平在IgG4-PHD鉴别诊断中的价值. 浙江临床医学. 2024(09): 1369-1371 .
2.	李红娟. 对比透射比浊法及散射比浊法对IgG、IgA、IgM免疫球蛋白的检测价值研究. 医药论坛杂志. 2024(21): 2344-2347+2353 .
3.	侯祥位，陈立侠，耿继儒. 血清IgG4及IgG4/IgG在IgG4相关性疾病及其他自身免疫性疾病诊断及鉴别诊断中的应用价值. 中国社区医师. 2023(05): 118-120 .
4.	徐思斌，周明宣. 糖皮质激素及免疫抑制剂治疗IgG4相关性疾病的疗效观察. 中国卫生标准管理. 2023(10): 128-132 .
5.	罗盈，王子霞，李彤，陈敏静，姚亚男，周晖. 血清IgG_4水平检测在IgG_4相关肝胆胰疾病诊断及疗效评估的价值研究. 现代检验医学杂志. 2022(06): 70-75 .

Other cited types(0)

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Figures(2) / Tables(2)

Get Citation

PDF

XML

Article Metrics

Article views (653) PDF downloads(50)

Value of serum IgG4 level in differential diagnosis of IgG4-related pancreatic and hepatobiliary diseases and non-IgG4-related pancreatic and hepatobiliary diseases

DOI: 10.3969/j.issn.1001-5256.2022.06.017